core shell structure Search Results


pdxau-pt core–shell structured metallic aerogels  (Verlag GmbH)
90
Verlag GmbH pdxau-pt core–shell structured metallic aerogels
Pdxau Pt Core–Shell Structured Metallic Aerogels, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/pm30536681-221-28-5?v=Verlag+GmbH
Average 90 stars, based on 1 article reviews
pdxau-pt core–shell structured metallic aerogels - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
open porous structured core-shell microtissue  (BioMimetic Therapeutics)
90
BioMimetic Therapeutics open porous structured core-shell microtissue
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Open Porous Structured Core Shell Microtissue, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/pmc06643438-32-7-6?v=BioMimetic+Therapeutics
Average 90 stars, based on 1 article reviews
open porous structured core-shell microtissue - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
core–shell structured microcapsules  (BioMimetic Therapeutics)
90
BioMimetic Therapeutics core–shell structured microcapsules
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Core–Shell Structured Microcapsules, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/10__1016_slash_j__colsurfa__2013__04__055-20-0-0?v=BioMimetic+Therapeutics
Average 90 stars, based on 1 article reviews
core–shell structured microcapsules - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
mbs methacrylate-butadiene-styrene emulsion copolymer impact modifier with core-shell structure  (SABIC Innovative Plastics)
90
SABIC Innovative Plastics mbs methacrylate-butadiene-styrene emulsion copolymer impact modifier with core-shell structure
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Mbs Methacrylate Butadiene Styrene Emulsion Copolymer Impact Modifier With Core Shell Structure, supplied by SABIC Innovative Plastics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/us07910657-290-16-34?v=SABIC+Innovative+Plastics
Average 90 stars, based on 1 article reviews
mbs methacrylate-butadiene-styrene emulsion copolymer impact modifier with core-shell structure - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
additively manufactured (cocrni)94(tial)6 medium-entropy alloy with a novel core-shell structured strengthening phase  (Jiangbo Pharmaceuticals)
90
Jiangbo Pharmaceuticals additively manufactured (cocrni)94(tial)6 medium-entropy alloy with a novel core-shell structured strengthening phase
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Additively Manufactured (Cocrni)94(tial)6 Medium Entropy Alloy With A Novel Core Shell Structured Strengthening Phase, supplied by Jiangbo Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/pm40004406-533-21-6?v=Jiangbo+Pharmaceuticals
Average 90 stars, based on 1 article reviews
additively manufactured (cocrni)94(tial)6 medium-entropy alloy with a novel core-shell structured strengthening phase - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
core-shell particles structures  (Rohm and Haas)
90
Rohm and Haas core-shell particles structures
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Core Shell Particles Structures, supplied by Rohm and Haas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/us10563085-127-3-8?v=Rohm+and+Haas
Average 90 stars, based on 1 article reviews
core-shell particles structures - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
mbs methacrylate-butadiene-styrene emulsion copolymer impact modifier core-shell structure  (Rohm and Haas)
90
Rohm and Haas mbs methacrylate-butadiene-styrene emulsion copolymer impact modifier core-shell structure
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Mbs Methacrylate Butadiene Styrene Emulsion Copolymer Impact Modifier Core Shell Structure, supplied by Rohm and Haas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/us07405250-381-14-31?v=Rohm+and+Haas
Average 90 stars, based on 1 article reviews
mbs methacrylate-butadiene-styrene emulsion copolymer impact modifier core-shell structure - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
impact modifier core/shell structure  (Rohm and Haas)
90
Rohm and Haas impact modifier core/shell structure
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Impact Modifier Core/Shell Structure, supplied by Rohm and Haas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/us07893135-258-4-14?v=Rohm+and+Haas
Average 90 stars, based on 1 article reviews
impact modifier core/shell structure - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
red blood cell based core–shell structured nanocomplexes  (BioMimetic Therapeutics)
90
BioMimetic Therapeutics red blood cell based core–shell structured nanocomplexes
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Red Blood Cell Based Core–Shell Structured Nanocomplexes, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/pm36476646-413-27-27?v=BioMimetic+Therapeutics
Average 90 stars, based on 1 article reviews
red blood cell based core–shell structured nanocomplexes - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
core-shell structured nanozyme with pda-mediated enhanced antioxidant efficiency  (Ruibang Laboratories)
90
Ruibang Laboratories core-shell structured nanozyme with pda-mediated enhanced antioxidant efficiency
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Core Shell Structured Nanozyme With Pda Mediated Enhanced Antioxidant Efficiency, supplied by Ruibang Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/pm38233333__am3c15938_si_001-0-6-18?v=Ruibang+Laboratories
Average 90 stars, based on 1 article reviews
core-shell structured nanozyme with pda-mediated enhanced antioxidant efficiency - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
quantum dots cdse/zns core/shell structure  (Ocean NanoTech)
90
Ocean NanoTech quantum dots cdse/zns core/shell structure
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Quantum Dots Cdse/Zns Core/Shell Structure, supplied by Ocean NanoTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/us09662299-548-6-12?v=Ocean+NanoTech
Average 90 stars, based on 1 article reviews
quantum dots cdse/zns core/shell structure - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
core-shell structure  (CH Instruments)
90
CH Instruments core-shell structure
Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell <t>microtissue</t> which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.
Core Shell Structure, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+shell+structure/pm32404579-35-5-22?v=CH+Instruments
Average 90 stars, based on 1 article reviews
core-shell structure - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell microtissue which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.

Journal: Theranostics

Article Title: Biomimetic open porous structured core-shell microtissue with enhanced mechanical properties for bottom-up bone tissue engineering

doi: 10.7150/thno.34464

Figure Lengend Snippet: Diagram of experimental design. Briefly, 10 mg/mL DBM particles were added into 60 mg/mL gelatin solution. The mixture was then ultrasonically dispersed until DBM particles were uniformly distributed. EDC/NHS were added to crosslink the precursor solution, and the crosslinked precursor solution was then pipetted into micro-stencil array chip, after which the lyophilized core-shell micro-scaffolds in the chip were harvested using an Ejector Pin array. BMSCs were seeded onto core-shell micro-scaffolds to form core-shell microtissue which was composed of DBM core loaded with BMP-2 and a gelatin shell enclosing the core. After the dynamic expansion and osteo-differentiation period in the perfusion bioreactor, the core-shell microtissues assembled together to form TEBGs. The assembled TEBGs were then implanted into rat critical sized cranial defect site to evaluate its ability to repair the defect.

Article Snippet: Against this background, we designed a biomimetic open porous structured core-shell microtissue with enhanced mechanical properties for BU bone tissue engineering as illustrated in Figure and Video SI .

Techniques:

H&E and immunohistochemical staining of CD31 in the subcutaneous model of different groups after 4 weeks implantation. (A, B) H&E staining found that core-shell microtissue has the most amount of new bone tissue compared to other groups (White arrows indicate remained DBM particles, black arrows indicate new bone tissue). (C) Immunohistostaining of CD31 showed that core-shell microtissues formed the most amount of newly capillaries (Red arrows indicate newly formed vessels). (D) The mean vessel numbers quantified using Image-Pro Plus 6.0 software. (*: p < 0.05, **: p < 0.01, scale bars in A: 500 μm, scale bars in B: 100 μm, scale bars in C: 25 μm)

Journal: Theranostics

Article Title: Biomimetic open porous structured core-shell microtissue with enhanced mechanical properties for bottom-up bone tissue engineering

doi: 10.7150/thno.34464

Figure Lengend Snippet: H&E and immunohistochemical staining of CD31 in the subcutaneous model of different groups after 4 weeks implantation. (A, B) H&E staining found that core-shell microtissue has the most amount of new bone tissue compared to other groups (White arrows indicate remained DBM particles, black arrows indicate new bone tissue). (C) Immunohistostaining of CD31 showed that core-shell microtissues formed the most amount of newly capillaries (Red arrows indicate newly formed vessels). (D) The mean vessel numbers quantified using Image-Pro Plus 6.0 software. (*: p < 0.05, **: p < 0.01, scale bars in A: 500 μm, scale bars in B: 100 μm, scale bars in C: 25 μm)

Article Snippet: Against this background, we designed a biomimetic open porous structured core-shell microtissue with enhanced mechanical properties for BU bone tissue engineering as illustrated in Figure and Video SI .

Techniques: Immunohistochemical staining, Staining, Software

Micro-CT analysis of TEBGs for rat critical sized bone defect treatment. (A-D) 3D images of defect sites treated by core-shell microtissue/core-shell micro-scaffold/gelatin microtissue/gelatin micro-scaffold based TEBGs were reconstructed at 4 weeks and 12 weeks post treatment, respectively. (The black dotted circles indicate 5 mm critical sized bone defect). (E-G) Quantitative analyses of BV, BV/TV ratio and BMD at week 4 and week 12. (*: p < 0.05, ***: p < 0.001)

Journal: Theranostics

Article Title: Biomimetic open porous structured core-shell microtissue with enhanced mechanical properties for bottom-up bone tissue engineering

doi: 10.7150/thno.34464

Figure Lengend Snippet: Micro-CT analysis of TEBGs for rat critical sized bone defect treatment. (A-D) 3D images of defect sites treated by core-shell microtissue/core-shell micro-scaffold/gelatin microtissue/gelatin micro-scaffold based TEBGs were reconstructed at 4 weeks and 12 weeks post treatment, respectively. (The black dotted circles indicate 5 mm critical sized bone defect). (E-G) Quantitative analyses of BV, BV/TV ratio and BMD at week 4 and week 12. (*: p < 0.05, ***: p < 0.001)

Article Snippet: Against this background, we designed a biomimetic open porous structured core-shell microtissue with enhanced mechanical properties for BU bone tissue engineering as illustrated in Figure and Video SI .

Techniques: Micro-CT

H&E, Masson's Trichrome staining and immuno-histochemical staining of col-1 and OCN of the defect sites after 12 weeks implantation. (A-D) Core-shell microtissue explant had a dense new bone tissue and the most calcium nodules in the defect site (Black arrows indicate the boarders of defect sites). (E, F) Immunohistochemical staining of col-1 and OCN (White arrows indicate the stained type 1 collagen, red arrows indicate OCN-positive cells). (Scale bars in A, C: 500 μm, scale bars in B: 100 μm, scale bars in D: 200 μm, scale bars in E, F: 50 μm)

Journal: Theranostics

Article Title: Biomimetic open porous structured core-shell microtissue with enhanced mechanical properties for bottom-up bone tissue engineering

doi: 10.7150/thno.34464

Figure Lengend Snippet: H&E, Masson's Trichrome staining and immuno-histochemical staining of col-1 and OCN of the defect sites after 12 weeks implantation. (A-D) Core-shell microtissue explant had a dense new bone tissue and the most calcium nodules in the defect site (Black arrows indicate the boarders of defect sites). (E, F) Immunohistochemical staining of col-1 and OCN (White arrows indicate the stained type 1 collagen, red arrows indicate OCN-positive cells). (Scale bars in A, C: 500 μm, scale bars in B: 100 μm, scale bars in D: 200 μm, scale bars in E, F: 50 μm)

Article Snippet: Against this background, we designed a biomimetic open porous structured core-shell microtissue with enhanced mechanical properties for BU bone tissue engineering as illustrated in Figure and Video SI .

Techniques: Staining, Immunohistochemical staining